TH98393A - Pharmaceutical Ingredients 457 - Google Patents
Pharmaceutical Ingredients 457Info
- Publication number
- TH98393A TH98393A TH701004111A TH0701004111A TH98393A TH 98393 A TH98393 A TH 98393A TH 701004111 A TH701004111 A TH 701004111A TH 0701004111 A TH0701004111 A TH 0701004111A TH 98393 A TH98393 A TH 98393A
- Authority
- TH
- Thailand
- Prior art keywords
- formula
- pharmaceutical
- hydroxythoxy
- pyrimidin
- cyclopropyl
- Prior art date
Links
- 239000004615 ingredient Substances 0.000 title 1
- -1 3,4 -Difluorophenyl Chemical group 0.000 claims abstract 8
- 239000005426 pharmaceutical component Substances 0.000 claims abstract 7
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims abstract 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract 5
- 150000001875 compounds Chemical class 0.000 claims abstract 4
- VCVOSERVUCJNPR-UHFFFAOYSA-N cyclopentane-1,2-diol Chemical compound OC1CCCC1O VCVOSERVUCJNPR-UHFFFAOYSA-N 0.000 claims abstract 4
- 239000000470 constituent Substances 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- FBPFZTCFMRRESA-KAZBKCHUSA-N D-Mannitol Natural products OC[C@@H](O)[C@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KAZBKCHUSA-N 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 239000002270 dispersing agent Substances 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims 1
- CKRORYDHXIRZCH-UHFFFAOYSA-N phosphoric acid;dihydrate Chemical compound O.O.OP(O)(O)=O CKRORYDHXIRZCH-UHFFFAOYSA-N 0.000 claims 1
Abstract
DC60 (29/01/52) การประดิษฐ์นี้ เกี่ยวข้องกับองค์ประกอบทางเภสัชกรรม และโดยเฉพาะมากกว่านั้น เกี่ยวข้องกับองค์ประกอบทางเภสัชกรรมที่มีสารประกอบ {1S-[1อัลฟา, 2อัลฟา, 3เบตา (1S*, 2R*), 5เบตา]}-3- (7-{[2-(3,4-ไดฟลูออโรฟีนิล) ไซโคลโพรพิล] อะมิโน}-5-(โพรพิลไธโอ)-3H-1,2,3-ไตรเอโซโล [4,5-d]ไพริมิดิน-3-อิล)-5-(2-ไฮดรอกซิเอธอกซิ)ไซโคลเพนเทน-1,2-ไดออล การประดิษฐ์นี้ เกี่ยวข้องกับองค์ประกอบทางเภสัชกรรม และโดยเฉพาะมากกว่านั้น เกี่ยวข้องกับองค์ประกอบทางเภสัชกรรมที่มีสารประกอบ {1S-[1(สูตร),2(สูตร),3(สูตร) (1S*,2R*),5(สูตร)]}-3- (7-{[2-(3,4-ไดฟลูออโรฟีนิล)ไซโคลโพรพิล]อะมิโน}-5-(โพรพิลไธโอ)-3H-1,2,3-ไตรเอโซโล [4,5-d]ไพริมิดิน-3-อิล)-5-(2-ไฮดรอกซิเอธอกซิ)ไซโคลเพนเทน-1,2-ไดออล สิทธิบัตรยา DC60 (29/01/52) invention of this Relating to the pharmaceutical components And more specifically Related to the pharmaceutical constituents with compounds {1S- [1 alpha, 2 alpha, 3 beta (1S *, 2R *), 5 beta]} - 3- (7 - {[2- (3,4 -Difluorophenyl) cyclopropyl] amino} -5- (propylthio) -3H-1,2,3-triazolo [4,5-d] pyrimidin-3-il) -5- (2-hydroxythoxy) cyclopentane-1,2-diol This invention Relating to the pharmaceutical components And more specifically Relating to a pharmaceutical component containing a compound {1S- [1 (formula), 2 (formula), 3 (formula) (1S *, 2R *), 5 (formula)]) - 3- (7 - {[2- (3,4-diploid) Orophenyl) cyclopropyl] amino) -5- (propylthio) -3H-1,2,3-triazolo [4,5-d] pyrimidin-3-il) -5- (2-hydroxythoxy) cyclopentane-1,2-diol, drug patent.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH98393A true TH98393A (en) | 2009-09-24 |
| TH98393B TH98393B (en) | 2009-09-24 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0715712B8 (en) | pharmaceutical composition suitable for oral administration comprising a triazol[4,5d]pyrimidine derivative | |
| CL2011000496A1 (en) | Process for the preparation of [1s- [1alpha, 2alfa, 3beta (1s *, 2r *), 5beta]] - 3- [7- [2- (3,4-difluorophenyl) -cyclopropylamino] -5- (propylthio) -3h-1,2,3-triazolo [4,5d] pyrimidin-3-yl] -5- (2-hydroxyethoxy) cyclopentane-1,2-diol based on the use of oxalate salts; and one of the intermediary compounds considered. | |
| MX343702B (en) | A process for the preparation of optically active cyclopropylamines. | |
| CR10091A (en) | ORGANIC COMPOUNDS | |
| RU2325389C2 (en) | Composition and derivatives of substituted azaindoloxoacetapiperazine characterized by antiviral activity | |
| EA200800360A1 (en) | FORMS WITH HIGH CONTENT OF DRUGS AND DOSED FORMS | |
| TW200621783A (en) | 1,4 substituted pyrazolopyrimidines as kinase inhibitors | |
| BR9810802A (en) | Compound, pharmaceutical composition, and, processes for preparing a compound, and for treating a platelet aggregating disease | |
| WO2007100382A3 (en) | Orally administrable gallium compositions and method of use | |
| CY1108067T1 (en) | Substituted 2-Pyridine-Cyclohexane-1,4-Diamine Derivatives | |
| EA200500891A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ALKALINE OR ACCORDINGLY ACIDAL MEDICINAL COMPOUNDS, SURFACE-ACTIVE SUBSTANCE AND PHYIOLOGICAL ACCEPTABLE WATER-INSULATED MATERIAL AND PHYIOLOGICAL ACCEPTABLE WATER-INSULATED MATERIAL AND PHYSIOLOGICAL ACCEPTABLE WATER-CONCENTRATIVE CHARACTERISTIC ACTIVITY AND PHYIOLOGICAL ACCEPTABLE WATER-CONCENTRATING SOURCES | |
| BRPI0519443A2 (en) | organic compounds | |
| MA34897B1 (en) | FORMATIONS OF IMMUNOSUPPRESSORS | |
| WO2007060408A3 (en) | L-phenylalanine derivatives and their use as integrin antagonists | |
| CY1105028T1 (en) | SUBSTITUTED C-IMIDAZO-[1,2-A]PYRIDIN-3-YL-METHYLAMINES | |
| BR9811028A (en) | Compound, pharmaceutical composition, and, processes for treating a platelet aggregating disease and for the preparation of a compound | |
| CY1105019T1 (en) | SUBSTITUTED C-IMIDAZO-[1,2-A]PYRIDIN-3-YL-METHYLAMINES | |
| EA200801447A1 (en) | PHARMACEUTICAL COMPOSITION | |
| TH98393A (en) | Pharmaceutical Ingredients 457 | |
| ES2522317T3 (en) | Ticagrelor for treatment of abdominal aortic aneurysms | |
| EA200500672A1 (en) | ALPHUSOSIN-CONTAINING COMPOSITIONS WITH EXTENDED DELIVERY | |
| WO2006111853A3 (en) | Stable solid dosage forms of acid labile drug | |
| TH98393B (en) | Pharmaceutical Ingredients 457 | |
| ECSP088236A (en) | FORMS AND COMPOSITIONS OF PHARMACEUTICAL DOSAGES | |
| MA53509A (en) | THERAPEUTIC AGENT CONTAINING PYRAZOLO[3,4-D]PYRIMIDINE COMPOUND AS ACTIVE INGREDIENT |